While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...

More information: One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice, JAMA Network Open (2024). DOI: 10.1001/jamanetworkopen.2024.33326. Provided by Cleveland Clinic.

A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic ...

In a randomized trial of 2.4-mg semaglutide, 3.0-mg liraglutide, and matching placebo for both, those on semaglutide plus diet and exercise saw a 9.4% greater average loss in baseline weight ...

That mark was reached by 28.6% of those taking liraglutide for obesity, 23.1% of semaglutide diabetics and 12.3% of liraglutide diabetics.

This retrospective cohort study included 3,389 adult patients with obesity who initiated treatment with injectable semaglutide or liraglutide between July 1, 2015, and June 30, 2022.

The researchers found that the mean percentage weight change at one year was –5.1% and –2.2% with semaglutide and liraglutide, respectively; –3.2% and –5.9% for T2D and obesity as ...

One-year weight reduction with semaglutide or liraglutide in clinical practice. JAMA Network. Journal JAMA Network Open. Keywords /Life sciences/Organismal biology/Morphology/Body weight/ Weight loss ...

Semaglutide and liraglutide were associated with risk for somatic hospitalization. Patients with alcohol use disorder who used GLP-1 agonists to treat obesity or type 2 diabetes had a decreased ...

The researchers found that the mean percentage weight change at one year was –5.1% and –2.2% with semaglutide and liraglutide, respectively; –3.2% and –5.9% for T2D and obesity as ...